Navigation Links
Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation
Date:6/19/2013

SANTA CLARA, Calif., June 19, 2013 /PRNewswire/ -- Finesse Solutions, Inc, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new SmartGlass™ autoclavable 3L glass bioreactors for upstream cell culture and fermentation.  The 3L glass vessels are the first in a new product family of Finesse bioreactors and are designed to optimize yield in both R&D and cGMP applications.  They are fully compatible with all Finesse G3Lab controllers, and with SmartAdapters can be utilized with third party controllers.

Designed for R&D and process development scale-up, SmartGlass vessels enable easier handling and faster assembly/disassembly for cleaning.  They were developed to be fully hygienic to ensure complete process sterility and minimize lost batches.  The vessels are manufactured with the highest standards for surface finish and safety of operation.

"We have made many design improvements to optimize the SmartGlass platform for cell culture and fermentation processes.  For examples, our cold finger has increased surface area to enable faster thermal control and increase cooling capacity so that a single-wall vessel can be used for fermentation.  We have also collaborated closely with the group of Profs. Dieter and Regine Eibl at the University of Wadenswil in Zurich, Switzerland, in order to create a novel impeller design that produces higher average kLa, and increases power transfer while minimizing shear. The vessels have been designed using all of the machinery available for computational fluid mechanics simulations," stated Dr. Mark Selker, Vice President of R&D and co-founder of Finesse Solutions.

About Finesse Solutions, Inc
California-based Finesse Solutions, Inc has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing.  The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer.  Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications. For more information, please visit us at www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, Inc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
2. Finesse Solutions Launches Next Generation G3Lab Universal SmartControllers to Enhance Productivity in Bench Scale Cell Culture and Fermentation
3. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
4. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
5. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
6. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
7. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
8. Ablative Solutions Completes $5.3M Series A Financing
9. DATATRAK Expands CDISC Registered Solutions Provider Standards
10. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
11. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):